LGCFX
Price
$18.28
Change
-$0.23 (-1.24%)
Updated
Jun 13 closing price
Net Assets
183.4M
RWIBX
Price
$67.65
Change
-$0.73 (-1.07%)
Updated
Jun 13 closing price
Net Assets
131.04B
Interact to see
Advertisement

LGCFX vs RWIBX

Header iconLGCFX vs RWIBX Comparison
Open Charts LGCFX vs RWIBXBanner chart's image
Lord Abbett Global Equity F
Price$18.28
Change-$0.23 (-1.24%)
VolumeN/A
Net Assets183.4M
American Funds Capital World Gr&Inc R2
Price$67.65
Change-$0.73 (-1.07%)
VolumeN/A
Net Assets131.04B
LGCFX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGCFX vs. RWIBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGCFX is a Buy and RWIBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 131B vs. LGCFX (183M). RWIBX pays higher dividends than LGCFX: RWIBX (0.86) vs LGCFX (0.50). LGCFX was incepted earlier than RWIBX: LGCFX (8 years) vs RWIBX (23 years). LGCFX (1.57) and RWIBX (1.51) have similar cost to investors . LGCFX is a more actively managed with annual turnover of: 41.00 vs. RWIBX (27.00). LGCFX has a lower initial minimum investment than RWIBX: LGCFX (0) vs RWIBX (250). LGCFX annual gain was more profitable for investors over the last year : 14.00 vs. RWIBX (5.45). LGCFX return over 5 years is better than : 66.91 vs. RWIBX (47.82).
LGCFXRWIBXLGCFX / RWIBX
Total Expense Ratio0.751.5150%
Annual Report Gross Expense Ratio1.571.51104%
Fund Existence8 years23 years-
Gain YTD9.6588.647112%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets183M131B0%
Annual Yield % from dividends0.500.8659%
Returns for 1 year14.005.45257%
Returns for 3 years64.4641.17157%
Returns for 5 years66.9147.82140%
Returns for 10 yearsN/A47.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCO76.530.13
+0.17%
Ducommun
OGN10.04-0.03
-0.30%
Organon & Co
IQV156.89-2.24
-1.41%
IQVIA Holdings
SGRP1.06-0.02
-1.85%
SPAR Group
VNDA4.51-0.12
-2.59%
Vanda Pharmaceuticals